COMMUNIQUÉS West-GlobeNewswire

-
Coloplast A/S - Interim Financial Report, Q1 2023/24
09/02/2024 -
KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
09/02/2024 -
IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
09/02/2024 -
IBA acquiert Radcal Corporation afin d’élargir son offre d'assurance qualité en imagerie médicale et renforcer sa présence aux États-Unis.
09/02/2024 -
Metagenomi Announces Pricing of Initial Public Offering
09/02/2024 -
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
08/02/2024 -
Telomir Pharmaceuticals Announces Pricing of Initial Public Offering
08/02/2024 -
Immix Biopharma Announces Closing of $15 Million Public Offering of Common Stock
08/02/2024 -
Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/02/2024 -
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
08/02/2024 -
Surgery Partners, Inc. Announces Fourth Quarter 2023 Earnings Release Date and Conference Call Details
08/02/2024 -
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
08/02/2024 -
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
08/02/2024 -
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
08/02/2024 -
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
08/02/2024 -
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
08/02/2024 -
Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma
08/02/2024 -
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
08/02/2024 -
BioXcel Therapeutics Announces Proposed Public Offering
08/02/2024
Pages